Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other Non-Current Assets (2016 - 2026)

Amphastar Pharmaceuticals has reported Other Non-Current Assets over the past 13 years, most recently at $31.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 19.79% year-over-year to $31.1 million; the TTM value through Dec 2025 reached $31.1 million, up 19.79%, while the annual FY2025 figure was $31.1 million, 19.79% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $31.1 million at Amphastar Pharmaceuticals, up from $29.9 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $31.1 million in Q4 2025 and troughed at $7.2 million in Q1 2021.
  • A 5-year average of $21.0 million and a median of $21.9 million in 2022 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 286.7% in 2021 and later dropped 6.47% in 2024.
  • Year by year, Other Non-Current Assets stood at $16.7 million in 2021, then increased by 25.15% to $20.9 million in 2022, then increased by 24.23% to $25.9 million in 2023, then rose by 0.32% to $26.0 million in 2024, then rose by 19.79% to $31.1 million in 2025.
  • Business Quant data shows Other Non-Current Assets for AMPH at $31.1 million in Q4 2025, $29.9 million in Q3 2025, and $28.1 million in Q2 2025.